These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35418909)
1. A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities. Nayak SM; Griffiths RR Front Psychol; 2022; 13():852248. PubMed ID: 35418909 [TBL] [Abstract][Full Text] [Related]
6. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Nour MM; Evans L; Nutt D; Carhart-Harris RL Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878 [TBL] [Abstract][Full Text] [Related]
7. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. Sweeney MM; Nayak S; Hurwitz ES; Mitchell LN; Swift TC; Griffiths RR PLoS One; 2022; 17(8):e0271926. PubMed ID: 36001643 [TBL] [Abstract][Full Text] [Related]
8. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268 [TBL] [Abstract][Full Text] [Related]
9. Naturalism and the hard problem of mysticism in psychedelic science. Jylkkä J Front Psychol; 2024; 15():1112103. PubMed ID: 38558777 [TBL] [Abstract][Full Text] [Related]
10. Psychedelics, Meditation, and Self-Consciousness. Millière R; Carhart-Harris RL; Roseman L; Trautwein FM; Berkovich-Ohana A Front Psychol; 2018; 9():1475. PubMed ID: 30245648 [TBL] [Abstract][Full Text] [Related]
12. What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes. Acevedo EC; Uhler S; White KP; Al-Shawaf L J Psychoactive Drugs; 2024 Feb; ():1-10. PubMed ID: 38341606 [TBL] [Abstract][Full Text] [Related]
13. Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects. Martial C; Carhart-Harris R; Timmermann C Neurosci Conscious; 2024; 2024(1):niae033. PubMed ID: 39220326 [TBL] [Abstract][Full Text] [Related]
14. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Sekula AD; Downey L; Puspanathan P Front Psychol; 2022; 13():813746. PubMed ID: 35310225 [TBL] [Abstract][Full Text] [Related]
15. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts. Graziosi M; Singh M; Nayak SM; Yaden DB J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890 [TBL] [Abstract][Full Text] [Related]
16. Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports. Žuljević MF; Mijatović A; Marušić SL; Kudrjavets G; Buljan I; Hren D J Psychoactive Drugs; 2023 Nov; ():1-13. PubMed ID: 37921118 [TBL] [Abstract][Full Text] [Related]
17. An introduction to psychedelic neuroscience. Calvey T; Howells FM Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677 [TBL] [Abstract][Full Text] [Related]
18. Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs. Tagliazucchi E Front Pharmacol; 2022; 13():812227. PubMed ID: 35392561 [TBL] [Abstract][Full Text] [Related]
19. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Davis AK; Barrett FS; Griffiths RR J Contextual Behav Sci; 2020 Jan; 15():39-45. PubMed ID: 32864325 [TBL] [Abstract][Full Text] [Related]
20. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]